Close Menu

NEW YORK (GenomeWeb) – Enzo Biochem reported today that its fiscal third quarter revenues climbed 10 percent over last year on a strong performance for its clinical lab and life science divisions.

For the three-month period ended April 30, the company reported total revenues of $26.4 million compared to $24 million in the same period a year earlier. Clinical lab services revenues grew 16 percent to $18.2 million from $15.7 million, while life sciences revenues edged up to $8 million from $7.9 million. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.